-
EU set to scrap 2035 combustion-engine ban in car industry boost
-
Australian PM visits Bondi Beach hero in hospital
-
'Easiest scam in the world': Musicians sound alarm over AI impersonators
-
'Waiting to die': the dirty business of recycling in Vietnam
-
Asian markets retreat ahead of US jobs as tech worries weigh
-
Security beefed up for Ashes Adelaide Test after Bondi shooting
-
Famed Jerusalem stone still sells despite West Bank economic woes
-
Trump sues BBC for $10 billion over documentary speech edit
-
Chile follows Latin American neighbors in lurching right
-
Will OpenAI be the next tech giant or next Netscape?
-
Khawaja left out as Australia's Cummins, Lyon back for 3rd Ashes Test
-
Australia PM says 'Islamic State ideology' drove Bondi Beach shooters
-
Scheffler wins fourth straight PGA Tour Player of the Year
-
Security beefed up for Ashes Test after Bondi shooting
-
Wembanyama blocking Knicks path in NBA Cup final
-
Amorim seeks clinical Man Utd after 'crazy' Bournemouth clash
-
Man Utd blow lead three times in 4-4 Bournemouth thriller
-
Stokes calls on England to 'show a bit of dog' in must-win Adelaide Test
-
Trump 'considering' push to reclassify marijuana as less dangerous
-
Chiefs coach Reid backing Mahomes recovery after knee injury
-
Trump says Ukraine deal close, Europe proposes peace force
-
French minister urges angry farmers to trust cow culls, vaccines
-
Angelina Jolie reveals mastectomy scars in Time France magazine
-
Paris Olympics, Paralympics 'net cost' drops to 2.8bn euros: think tank
-
Chile president-elect dials down right-wing rhetoric, vows unity
-
Five Rob Reiner films that rocked, romanced and riveted
-
Rob Reiner: Hollywood giant and political activist
-
Observers say Honduran election fair, but urge faster count
-
Europe proposes Ukraine peace force as Zelensky hails 'real progress' with US
-
Trump condemned for saying critical filmmaker brought on own murder
-
US military to use Trinidad airports, on Venezuela's doorstep
-
Daughter warns China not to make Jimmy Lai a 'martyr'
-
UK defence chief says 'whole nation' must meet global threats
-
Rob Reiner's death: what we know
-
Zelensky hails 'real progress' in Berlin talks with Trump envoys
-
Toulouse handed two-point deduction for salary cap breach
-
Son arrested for murder of movie director Rob Reiner and wife
-
Stock market optimism returns after tech selloff but Wall Street wobbles
-
Clarke warns Scotland fans over sky-high World Cup prices
-
In Israel, Sydney attack casts shadow over Hanukkah
-
Son arrested after Rob Reiner and wife found dead: US media
-
Athletes to stay in pop-up cabins in the woods at Winter Olympics
-
England seek their own Bradman in bid for historic Ashes comeback
-
Decades after Bosman, football's transfer war rages on
-
Ukraine hails 'real progress' in Zelensky's talks with US envoys
-
Nobel winner Machado suffered vertebra fracture leaving Venezuela
-
Stock market optimism returns after tech sell-off
-
Iran Nobel winner unwell after 'violent' arrest: supporters
-
Police suspect murder in deaths of Hollywood giant Rob Reiner and wife
-
'Angry' Louvre workers' strike shuts out thousands of tourists
Dalrada Financial Corporation's Deposition Technology Makes Spectroptix(R) Available for Advance Ordering
Deptec's plasma spectrometer is primed to play an integral role in the booming semiconductor manufacturing and thin-film sectors.
Dalrada Financial Corporation(OTC PINK:DFCO), "Dalrada," "the Company"), announced today that Spectroptix®, a proprietary advanced plasma spectrometer developed by its subsidiary, Deposition Technology ("Deptec,"), is now available for advance ordering.
The one-of-a-kind spectrometer is designed for precise element detection in vacuum chambers during deposition or semiconductor manufacturing processes, allowing for the integration of advanced plasma spectroscopy. This specialized tool also offers a host of other key features and benefits, according to Brian Bonar, Dalrada's Chairman and CEO.
"Spectroptix® is the ideal machine for the semiconductor industry," said Bonar. "For starters, it can be integrated into various vacuum-based processes, from thin film coatings to plasma-enhanced CVD and PVD systems. It's also quite easy to operate. Spectroptix® will be a real game-changer in the microchip and semiconductor world and we're quite thrilled to offer pre-ordering for our clients."
Deptec's Spectroptix® delivers real-time actionable data on materials within each vacuum chamber during the deposition process, ensuring higher accuracy, efficiency, and process control. Other benefits of the advanced spectrometer include:
Plasma creation: a background plasma independent of the deposition process, ensuring that no process contamination or interference occurs during analysis.
Enhanced Process Control: using real-time data, Spectroptix® enables precise control over deposition environments, allowing for on-the-fly adjustments to gas flow or composition.
User-Friendly Interface: intuitive software control that allows remote operation for operators to visualize and analyze light spectrum data for efficient optimization.
Preferred over Residual Gas Analyzers (RGAs): more cost-effective solution than RGAs, plus RGAs do not come standard with vacuum technology.
Deptec's Spectroptix® is particularly well-suited for applications requiring ultra-thin films and sensitive optical coatings, like semiconductor manufacturing, microelectronics, optoelectronics, advanced material processing, and more. Future target markets include pharmaceuticals, aerospace/defense, materials science, nuclear industries, and food and beverage.
With a mature product line firmly in place within the deposition technology marketplace, Deptec has its sights on further expanding its unique portfolio, adding robust solutions to include a new chemical vapor deposition (CVD) platform-the EVOS CVD system-which would join the company's popular Novellus C1 upgrade kit for legacy CVD machines.
"With our increased production and installation capabilities plus the rollout of new products providing even greater opportunities, making Spectroptix® available for pre-ordering is just the beginning," added Bonar.
About Dalrada Financial Corporation
Dalrada Financial Corporation(OTC PINK:DFCO) is a multi-national holding company that develops, manufactures, and sells a robust suite of products and services in the Clean Energy, Physical and Chemical Vapor Deposition for Semiconductors, and Health Care sectors. Dalrada's core segments include Dalrada Climate Technology, which offers cutting-edge heat pump and energy sustainability technology for industrial and residential applications; Deptec, an international leader in deposition technology and manufacturing that repurposes and sells proprietary semiconductor technology for clean energy applications; and Genefic Specialty Pharmacy, which provides end-to-end prescription and specialty pharmacy services as well as patient advocacy and support.
Dalrada consistently drives innovation that delivers maximum impact, bringing increased value to its shareholders.
For more information, please visit www.dalrada.com, and follow us on LinkedIn, Facebook, Twitter, and YouTube.
About Deposition Technology
Deposition Technology (Deptec) is a wholly-owned subsidiary of Dalrada Financial Corporation(OTC PINK:DFCO), and an international leader in precision manufacturing, specializing in thin-film deposition including PVD (Physical Vapor Deposition) and CVD (Chemical Vapor Deposition) processing and equipment.
Founded in 2004, Deptec has expanded to specialize in upgrading legacy tools, including Novellus Concept One, and delivering innovative solutions like Spectroptix for advanced material detection. The company's products and services are designed to enhance the performance, reliability, and cost-efficiency of manufacturing processes in the semiconductor, MEMS, and optoelectronics industries.
Forward-Looking Statements
Statements contained in this press release, other than statements of historical fact, particularly statements relating to cost reductions and the anticipated pre-tax savings from the cost reduction program, restructuring costs, footprint rationalization, simplifying and streamlining our operations, reducing complexity, enhancing the speed of decision-making, leveraging our sourcing capabilities and the timing of implementation and completion of the cost reduction program, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of management based on information available to us at the time such statements are made. These statements, which are generally identifiable by the use of the words "will," "believe," "expect," "intend," "anticipate," "estimate," "forecast," "project," "plan," and similar expressions, are subject to certain risks and uncertainties, are made as of the date hereof, and we undertake no duty or obligation to update them. Forward-looking statements are subject to the occurrence of many events outside the Company's control and actual results and the timing of events may differ materially from those suggested or implied by such forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the US Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.
Media contact: Michael Eslinger ([email protected])
# # #
SOURCE: Dalrada Financial Corporation
T.Sanchez--AT